Back
Avalo Therapeutics Quote, Financials, Valuation and Earnings
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
31
AVTX
Avalo Therapeutics
Last Price:
9.30
Seasonality Move:
10.12%
7 Day Trial
ALL ACCESS PASS
$
7
The dark truth about AI
Click here to learn more...Avalo Therapeutics Price Quote
$9.30
+0.07 (+2.09%)
(Updated: December 14, 2024 at 5:24 AM ET)
Avalo Therapeutics Key Stats
Sell
31
Avalo Therapeutics (AVTX)
is a Sell
Day range:
$8.77 - $9.40
52-week range:
$3.95 - $34.46
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.58%
Volume:
189.1K
Avg. volume:
80.1K
1-year change:
-34.82%
Market cap:
$96.6M
Revenue:
$1.9M
EPS:
$-3530.82
How Much Does Avalo Therapeutics Make?
Data Unavailable
Is Avalo Therapeutics Growing As A Company?
-
What Is Avalo Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.06% -
What Is Avalo Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Avalo Therapeutics Stock Price Performance
-
Did Avalo Therapeutics Stock Go Up Last Month?
Avalo Therapeutics share price went down by -31.12% last month -
Did AVTX's Share Price Rise Over The Last Year?
AVTX share price fell by -34.82% over the past 1 year
What Is Avalo Therapeutics 52-Week High & Low?
-
What Is Avalo Therapeutics’s 52-Week High Share Price?
Avalo Therapeutics has traded as high as $34.46 over the past 52 weeks -
What Is Avalo Therapeutics’s 52-Week Low Share Price?
Avalo Therapeutics has traded as low as $3.95 over the past 52 weeks
Avalo Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Avalo Therapeutics?
-
How Much Debt Does Avalo Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Avalo Therapeutics Have?
Cash and short term investments quarterly total is $81.9M -
What Is Avalo Therapeutics’s Book Value Per Share?
Book value per share is 2.18
Is Avalo Therapeutics Cash Flow Positive?
-
What Is AVTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$36.8M -
What Is Avalo Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $108.1M -
What Is Avalo Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $356K
Avalo Therapeutics Return On Invested Capital
Data Unavailable
Avalo Therapeutics Earnings Date & Stock Price
-
What Is Avalo Therapeutics's Stock Price Today?
A single share of AVTX can be purchased today for 9.23 -
What Is Avalo Therapeutics’s Stock Symbol?
Avalo Therapeutics trades on the nasdaq under the ticker symbol: AVTX -
When Is Avalo Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Avalo Therapeutics is scheduled on May 13, 2025 -
When Is AVTX's next ex-dividend date?
Avalo Therapeutics's next ex-dividend date is December 15, 2024 -
How To Buy Avalo Therapeutics Stock?
You can buy Avalo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Avalo Therapeutics Competitors
-
Who Are Avalo Therapeutics's Competitors?
Below is a list of companies who compete with Avalo Therapeutics or are related in some way:
Avalo Therapeutics Dividend Yield
-
What Is AVTX Dividend Yield?
Avalo Therapeutics’s dividend yield currently is 0% -
What Is Avalo Therapeutics’s Payout Ratio?
Avalo Therapeutics’s payout ratio is 0% -
When Did Avalo Therapeutics Last Pay A Dividend?
The latest dividend pay date is December 15, 2024 -
What Is Avalo Therapeutics’s Dividend Per Share?
Avalo Therapeutics pays a dividend of $0.00 per share
Avalo Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 5.51% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 35.00 |
| Upside from Last Price: | 279.2% |